Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis - Wikidata - awgldk - TriplyDB

Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis

Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis

http://www.wikidata.org/entity/Q33422064

about

Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support.

P2860

Q38641761-8A632230-63B6-40AF-922B-DCDDAF2BD62E

P2860

Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis

http://www.wikidata.org/entity/Q33422064

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Safety and economic considerat ...... ents: a retrospective analysis

@ast

Safety and economic considerat ...... ents: a retrospective analysis

@en

type

label

Safety and economic considerat ...... ents: a retrospective analysis

@ast

Safety and economic considerat ...... ents: a retrospective analysis

@en

prefLabel

Safety and economic considerat ...... ents: a retrospective analysis

@ast

Safety and economic considerat ...... ents: a retrospective analysis

@en

P1433

Q33422064-0BE2D9AD-D857-4770-8B2E-717BDF313524

P1476

Q33422064-EA6A63F8-40D1-48A8-ABCB-828C12361B2C

P2093

Q33422064-093ECFC7-4D97-4C83-A9AE-0FF49110D76A

Q33422064-096D80AB-C0B4-402A-BC33-062FD5A7843B

Q33422064-102AE56D-D12E-40C3-AB4C-1AFE0BE3E6D4

Q33422064-1E7B3191-17FB-472E-89F1-FD1A750C68F2

Q33422064-3283D871-DFBA-493A-99D3-589103F70FC0

Q33422064-728103B9-CBF9-4592-9099-B5A230C68DCC

Q33422064-B0E34AF9-99EF-44BC-9252-8AA72EA5E07E

Q33422064-BF79135D-4157-48ED-9561-713C1C00C3DB

P2860

Q33422064-1A56FD25-E6B8-4B8B-8445-CE16509B9AB4

Q33422064-1D6DB048-9AC0-4297-A676-9867E2157D1C

Q33422064-20762FA0-2D9C-4737-95C0-960F5A6497E2

Q33422064-25344202-2596-4B6D-B688-E369D55913DF

Q33422064-28FCED8B-D57D-42A2-8B9A-0D21C17E0C2B

Q33422064-30B06B5E-1016-47E0-8BC1-33E0138CBB90

Q33422064-30FF3192-FAA9-4552-80DB-BD603D8FE707

Q33422064-39F2FE28-166F-4658-9996-ACFF166FC951

Q33422064-3CA31815-A0DE-46F4-B5E8-A499D8E6B105

Q33422064-40AC415A-EE67-436B-A5DB-17C8359134C8

P2888

Q33422064-DA5A0763-C968-4B6D-AD07-3AE62F3BEA66

P304

Q33422064-82347B04-A97A-4E05-9AEC-50335102AF22

P31

Q33422064-39984147-DFCA-4F70-A59C-F668FB2DDD55

P356

Q33422064-3FFEABD8-7E32-4DC6-B9CD-EF8FCD4D9BCF

P478

Q33422064-5BF42E1E-66B7-489D-8DC8-4F115F748DD1

P577

Q33422064-7E161913-4BE3-4062-9B57-54DA1650951A

P5875

Q33422064-DF403067-4537-4AEA-8CFB-28AA6E0735FB

P6179

Q33422064-CFE0CC3D-8039-48F4-886E-819F4AD729AF

P698

Q33422064-BBAC22C1-AA45-43E8-B222-0CD464257B47

P932

Q33422064-84DED4B1-A82D-483C-99FF-E66230A4D21E

P356

S13019-015-0214-0

P1433

Journal of Cardiothoracic Surgery

P1476

Safety and economic considerat ...... ents: a retrospective analysis

@en

P2093

Andreas Hoeft

http://www.w3.org/2001/XMLSchema#string

Georg Baumgarten

http://www.w3.org/2001/XMLSchema#string

Ingo Graeff

http://www.w3.org/2001/XMLSchema#string

Jens-Christian Schewe

http://www.w3.org/2001/XMLSchema#string

Maria Wittmann

http://www.w3.org/2001/XMLSchema#string

Nicole Tran

http://www.w3.org/2001/XMLSchema#string

Olaf Boehm

http://www.w3.org/2001/XMLSchema#string

Se-Chan Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Acute respiratory distress syndrome: the Berlin Definition

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.

Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.

Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.

Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.

Thrombocytopenia due to acute venous thromboembolism and its role in expanding the differential diagnosis of heparin-induced thrombocytopenia.

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients.

Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update.

P2888

s13019-015-0214-0

P304

19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13019-015-0214-0

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272378254

http://www.w3.org/2001/XMLSchema#string

P6179

1019633155

http://www.w3.org/2001/XMLSchema#string

P698

25879883

http://www.w3.org/2001/XMLSchema#string

P932

4332969

http://www.w3.org/2001/XMLSchema#string